Boundless Historical Financial Ratios
| BOLD Stock | USD 2.59 0.07 2.78% |
Boundless Bio, is presently reporting on over 72 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, Days Sales Outstanding of 0.0 or Invested Capital of 0.0 will help investors to properly organize and evaluate Boundless Bio, Common financial condition quickly.
Boundless |
About Boundless Financial Ratios Analysis
Boundless Bio, CommonFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Boundless Bio, investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Boundless financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Boundless Bio, history.
Boundless Bio, Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Boundless Bio, Common stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Boundless Bio, sales, a figure that is much harder to manipulate than other Boundless Bio, Common multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is Boundless Bio, Common dividend as a percentage of Boundless Bio, stock price. Boundless Bio, Common dividend yield is a measure of Boundless Bio, stock productivity, which can be interpreted as interest rate earned on an Boundless Bio, investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Free Cash Flow Yield
A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.Most ratios from Boundless Bio,'s fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Boundless Bio, Common current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boundless Bio, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. At present, Boundless Bio,'s ROE is projected to increase slightly based on the last few years of reporting. The current year's EV To Operating Cash Flow is expected to grow to 0.48, whereas Book Value Per Share is projected to grow to (5.43).
| 2023 | 2024 (projected) | Net Debt To EBITDA | 0.44 | 0.74 | Intangibles To Total Assets | 0.0283 | 0.0269 |
Boundless Bio, fundamentals Correlations
Click cells to compare fundamentals
Boundless Bio, Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Boundless Bio, fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Book Value Per Share | 3.56 | 10.06 | (1.72) | (3.67) | (5.71) | (5.43) | |
| Free Cash Flow Yield | (0.0669) | (0.13) | (0.019) | (182.8K) | (213.5K) | (202.9K) | |
| Operating Cash Flow Per Share | (1.92) | (2.45) | (1.05) | (1.78) | (2.11) | (2.21) | |
| Capex To Depreciation | 2.01 | 1.56 | 2.98 | 1.13 | 0.66 | 0.63 | |
| Free Cash Flow Per Share | (2.09) | (2.72) | (1.14) | (1.83) | (2.14) | (2.24) | |
| Roic | (0.56) | (0.31) | 0.66 | 0.56 | 0.43 | 0.45 | |
| Net Income Per Share | (2.05) | (2.93) | (1.13) | (2.06) | (2.22) | (2.33) | |
| Cash Per Share | 3.03 | 9.41 | 3.28 | 3.0 | 5.43 | 3.54 | |
| Capex To Operating Cash Flow | (0.0894) | (0.11) | (0.0875) | (0.0269) | (0.0135) | (0.0142) | |
| Income Quality | 0.94 | 0.84 | 0.92 | 0.86 | 0.95 | 0.71 | |
| Roe | (0.58) | (0.29) | 0.66 | 0.56 | 0.39 | 0.41 | |
| Ev To Operating Cash Flow | (15.9) | (7.42) | (55.91) | 0.15 | 0.46 | 0.48 | |
| Return On Tangible Assets | (0.54) | (0.28) | (0.22) | (0.6) | (0.38) | (0.4) | |
| Ev To Free Cash Flow | (14.6) | (6.7) | (51.41) | 0.14 | 0.45 | 0.48 | |
| Earnings Yield | (0.0656) | (0.14) | (0.0189) | (206.4K) | (222.3K) | (211.2K) | |
| Net Debt To E B I T D A | 0.36 | 1.13 | 1.38 | 0.13 | 0.44 | 0.74 | |
| Current Ratio | 7.74 | 17.6 | 19.28 | 8.8 | 13.27 | 10.04 | |
| Tangible Book Value Per Share | 3.29 | 9.79 | (1.72) | (3.67) | (5.71) | (5.43) | |
| Graham Number | 12.81 | 25.73 | 6.62 | 13.06 | 16.91 | 11.23 | |
| Shareholders Equity Per Share | 3.56 | 10.06 | (1.72) | (3.67) | (5.71) | (5.43) | |
| Capex Per Share | 0.17 | 0.26 | 0.0915 | 0.0479 | 0.0285 | 0.027 | |
| Graham Net Net | 2.53 | 8.73 | (3.55) | (4.13) | (6.13) | (5.82) | |
| Enterprise Value Over E B I T D A | (15.15) | (6.6) | (52.8) | 0.13 | 0.44 | 0.47 | |
| Effective Tax Rate | 0.0243 | (0.0431) | 0.003808 | 0.0146 | 0.0131 | 0.0138 | |
| Company Equity Multiplier | 1.14 | 1.07 | (2.98) | (0.94) | (1.02) | (0.97) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Boundless Bio, Common is a strong investment it is important to analyze Boundless Bio,'s competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Boundless Bio,'s future performance. For an informed investment choice regarding Boundless Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boundless Bio, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Boundless Bio,. If investors know Boundless will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Boundless Bio, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.59) | Return On Assets (0.24) | Return On Equity (0.36) |
The market value of Boundless Bio, Common is measured differently than its book value, which is the value of Boundless that is recorded on the company's balance sheet. Investors also form their own opinion of Boundless Bio,'s value that differs from its market value or its book value, called intrinsic value, which is Boundless Bio,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Boundless Bio,'s market value can be influenced by many factors that don't directly affect Boundless Bio,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Boundless Bio,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Boundless Bio, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Boundless Bio,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.